Suppr超能文献

血管加压素联合肾上腺素与单独使用肾上腺素治疗院外心脏骤停患者的疗效:一项系统评价和荟萃分析。

Efficacy of vasopressin-epinephrine compared to epinephrine alone for out of hospital cardiac arrest patients: A systematic review and meta-analysis.

作者信息

Zhang Qiang, Liu Bo, Zhao Lianxing, Qi Zhijiang, Shao Huan, An Le, Li Chunsheng

机构信息

Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chao-Yang Hospital,Capital Medical University, Beijing 100020, China.

Department of Emergency Intensive Care Unit, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China.

出版信息

Am J Emerg Med. 2017 Oct;35(10):1555-1560. doi: 10.1016/j.ajem.2017.07.040. Epub 2017 Jul 18.

Abstract

OBJECTIVE

The aim of this study was to conduct a meta-analysis to evaluate the efficacy of vasopressin-epinephrine compared to epinephrine alone in patients who suffered out-of-hospital cardiac arrest (OHCA).

METHODS

Relevant studies up to February 2017 were identified by searching in PubMed, EMBASE, the Cochrane Library, Wanfang for randomized controlled trials(RCTs) assigning adults with cardiac arrest to treatment with vasopressin-epinephrine (VEgroup) vs adrenaline (epinephrine) alone (E group). The outcome point was return of spontaneous circulation (ROSC) for patients suffering from OHCA. Heterogeneity, subgroup analysis, sensitivity analysis and publication bias were explored.

RESULTS

Individual patient data were obtained from 5047 participants who experienced OHCA in nine studies. Odds ratios (ORs) were calculated using a random-effects model and results suggested that vasopressin-epinephrine was associated with higher rate of ROSC (OR=1.67, 95% CI=1.13-2.49, P<0.00001, and total I=83%). Subgroup showed that vasopressin-epinephrine has a significant association with improvements in ROSC for patients from Asia (OR=3.30, 95% CI=1.30-7.88); but for patients from other regions, there was no difference between vasopressin-epinephrine and epinephrine alone (OR=1.07, 95% CI=0.72-1.61).

CONCLUSION

According to the pooled results of the subgroup, combination of vasopressin and adrenaline can improve ROSC of OHCA from Asia, but patients from other regions who suffered from OHCA cannot benefit from combination of vasopressin and epinephrine.

摘要

目的

本研究旨在进行一项荟萃分析,以评估血管加压素 - 肾上腺素与单独使用肾上腺素相比,在院外心脏骤停(OHCA)患者中的疗效。

方法

通过检索PubMed、EMBASE、Cochrane图书馆、万方数据库,查找截至2017年2月的相关随机对照试验(RCT),这些试验将心脏骤停的成年人分配至血管加压素 - 肾上腺素治疗组(VE组)与单独使用肾上腺素(E组)进行治疗。观察终点为OHCA患者的自主循环恢复(ROSC)。探讨了异质性、亚组分析、敏感性分析和发表偏倚。

结果

从9项研究中纳入了5047名经历OHCA的参与者的个体患者数据。采用随机效应模型计算比值比(OR),结果表明血管加压素 - 肾上腺素与更高的ROSC发生率相关(OR = 1.67,95% CI = 1.13 - 2.49,P < 0.00001,I² = 83%)。亚组分析显示,血管加压素 - 肾上腺素与亚洲患者ROSC改善显著相关(OR = 3.30,95% CI = 1.30 - 7.88);但对于其他地区的患者,血管加压素 - 肾上腺素与单独使用肾上腺素之间无差异(OR = 1.‌07,95% CI = 0.72 - 1.61)。

结论

根据亚组汇总结果,血管加压素与肾上腺素联合使用可改善亚洲OHCA患者的ROSC,但其他地区的OHCA患者无法从血管加压素与肾上腺素联合使用中获益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验